◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › R › RDNT

RadNet Inc (RDNT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DIAGNOSTICS & RESEARCH · DATA UPDATED 2026-08-16

RadNet Inc (RDNT) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Los Angeles, United States with about 11,000 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, RDNT reported $2.0B in revenue and ($19M) in net income.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health.

Interactive charts & full statements → Open the RDNT valuation workbench →

RDNT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.3B	$2.0B	$1.8B	$1.6B	$1.4B	$1.3B	$1.1B	$1.2B	$975M	$922M	$885M	$810M	$718M	$703M	$647M	$620M	$549M	$524M	$502M	$425M	$161M
Gross Profit	$220M	$91M	$249M	$221M	$166M	$192M	$106M	$154M	$108M	$120M	$109M	$101M	$115M	$104M	$104M	$142M	$128M	$127M	$118M	$95M	$41M
Gross Margin %	9.7%	4.5%	13.6%	13.7%	11.6%	14.6%	9.9%	13.4%	11.0%	13.0%	12.3%	12.5%	16.0%	14.8%	16.1%	22.9%	23.3%	24.1%	23.5%	22.3%	25.3%
Operating Income (EBIT)	$91M	$91M	$105M	$99M	$46M	$83M	$36M	$70M	$31M	$50M	$38M	$39M	$53M	$44M	$45M	$51M	$38M	$39M	$33M	$21M	$16M
Operating Margin %	4.0%	4.5%	5.7%	6.1%	3.2%	6.3%	3.3%	6.0%	3.2%	5.4%	4.3%	4.8%	7.4%	6.2%	7.0%	8.2%	7.0%	7.4%	6.5%	5.0%	10.1%
Net Income	($21M)	($19M)	$3M	$3M	$11M	$25M	($15M)	$15M	$32M	$0M	$7M	$8M	$1M	$2M	$65M	$7M	($13M)	($2M)	($13M)	($18M)	($7M)
Net Margin %	-0.9%	-0.9%	0.1%	0.2%	0.7%	1.9%	-1.4%	1.3%	3.3%	0.0%	0.8%	0.9%	0.2%	0.3%	10.0%	1.2%	-2.3%	-0.4%	-2.6%	-4.3%	-4.3%
EBITDA	$337M	$254M	$263M	$293M	$279M	$278M	$200M	$225M	$108M	$120M	$109M	$117M	$115M	$104M	$109M	$106M	$81M	$85M	$87M	$68M	$33M
Earnings Per Share (EPS)	$-0.27	$-0.25	$0.04	$0.05	$0.19	$0.46	$-0.29	$0.29	$0.66	$0.00	$0.15	$0.17	$0.03	$0.05	$1.64	$0.19	$-0.35	$-0.06	$-0.36	$-0.52	$-0.33
Shares Outstanding (M)	79M	75M	75M	65M	57M	53M	51M	50M	49M	47M	47M	45M	43M	40M	39M	39M	37M	36M	36M	35M	21M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDNT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$623M	$576M	$548M	$523M	$498M	$471M	$477M	$461M
Gross Profit	$88M	($16M)	$76M	$72M	$69M	$18M	$66M	$69M
Gross Margin %	14.1%	-2.9%	13.9%	13.9%	13.9%	3.8%	13.8%	15.0%
Operating Income (EBIT)	$39M	($16M)	$35M	$33M	$31M	($24M)	$25M	$34M
Operating Margin %	6.3%	-2.9%	6.4%	6.2%	6.2%	-5.1%	5.1%	7.3%
Net Income	$8M	($33M)	($1M)	$5M	$14M	($38M)	$5M	$3M
Net Margin %	1.2%	-5.8%	-0.1%	1.0%	2.9%	-8.1%	1.1%	0.7%
EBITDA	$90M	$30M	$140M	$77M	$77M	$20M	$66M	$71M
Earnings Per Share (EPS)	$0.10	$-0.43	$-0.01	$0.07	$0.20	$-0.51	$0.07	$0.04
Shares Outstanding (M)	79M	77M	75M	75M	74M	74M	76M	75M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDNT Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$317M	$299M	$233M	$221M	$146M	$149M	$234M	$104M	$117M	$141M	$92M	$67M	$61M	$66M	$74M	$58M	$67M	$77M	$45M	$29M	$10M
Capital Expenditures (CapEx)	$515M	$213M	$188M	$177M	$249M	$221M	$125M	$101M	$145M	$89M	$66M	$134M	$51M	$56M	$90M	$86M	$102M	$37M	$58M	$46M	$9M
Free Cash Flow (FCF)	($198M)	$86M	$45M	$44M	($103M)	($71M)	$108M	$3M	($29M)	$52M	$26M	($67M)	$10M	$11M	($16M)	($28M)	($35M)	$40M	($13M)	($16M)	$1M
FCF Margin %	-8.7%	4.2%	2.5%	2.7%	-7.2%	-5.4%	10.1%	0.3%	-2.9%	5.7%	2.9%	-8.2%	1.4%	1.5%	-2.5%	-4.5%	-6.4%	7.6%	-2.6%	-3.9%	0.5%
Dividends Paid	—	—	—	—	—	$6M	$2M	—	$1M	$2M	$0M	$1M	$0M	$12M	$12M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDNT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$88M	$92M	$84M	$53M	$120M	$41M	$43M	$57M
Capital Expenditures (CapEx)	$70M	$70M	$315M	$60M	$53M	$49M	$43M	$41M
Free Cash Flow (FCF)	$18M	$22M	($231M)	($8M)	$67M	($7M)	$0M	$16M
FCF Margin %	2.9%	3.9%	-42.1%	-1.5%	13.5%	-1.6%	-0.1%	3.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDNT Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$4.2B	$3.8B	$3.3B	$2.7B	$2.4B	$2.1B	$1.8B	$1.6B	$1.1B	$869M	$849M	$838M	$741M	$723M	$715M	$619M	$540M	$481M	$496M	$434M	$131M
Cash & Cash Equivalents	$726M	$767M	$740M	$343M	$128M	$135M	$102M	$40M	$10M	$51M	$21M	$0M	$0M	$8M	$0M	$2M	$1M	$10M	($24M)	$0M	$0M
Total Liabilities	$2.8B	$2.4B	$2.2B	$1.9B	$1.9B	$1.7B	$1.5B	$1.4B	$909M	$799M	$797M	$802M	$733M	$720M	$717M	$689M	$622M	$555M	$577M	$503M	$210M
Total Debt (Short + Long-Term)	$100M	$1.2B	$1.1B	$886M	$909M	$820M	$721M	$821M	$671M	$610M	$31M	$33M	$31M	$11M	$14M	$562M	$514M	$451M	$466M	$422M	$182M
Total Shareholders' Equity	$1.1B	$1.1B	$902M	$631M	$333M	$229M	$166M	$152M	$127M	$62M	$48M	$33M	$5M	$0M	($3M)	($71M)	($83M)	($75M)	($81M)	($70M)	($79M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RDNT viewer.

Other Companies in DIAGNOSTICS & RESEARCH

MEDP · Medpace Holdings Inc — $17 billion
ICLR · ICON PLC — $13 billion
TWST · Twist Bioscience Corp — $11 billion
QGEN · Qiagen NV — $9 billion
SHC · Sotera Health Co — $5 billion
BLLN · BillionToOne, Inc. Class A Common Stock — $5 billion
ADPT · Adaptive Biotechnologies Corp — $5 billion
GRAL · GRAIL, LLC — $4 billion

← RDN All “R” companies RDNW →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.